Topic archive

robert f. kennedy jr.

10 stories

9/10/2026

Filament Health plans stability program for ibogaine drug

IBEX011 stability program aims to meet growing demand for standardized ibogaine.

9/1/2026

The study aims to explore ibogaine's potential for treating PTSD and addiction.

8/21/2026

Trump administration accelerates psychedelic research for veterans' mental health.

8/20/2026

Dr. Heidi Overton, nominated by Trump, expedited psychedelic research policy.

8/19/2026

Heidi Overton's nomination could advance psychedelic therapies but raises vaccine concerns.

8/19/2026

Trump's administration advances psychedelic therapies for PTSD and TBI in veterans.

8/19/2026

Trump announces transfer of ibogaine investigational drug application to accelerate research.

8/19/2026

Barrow Neurological Institute to explore ibogaine's potential for PTSD and brain injuries.

7/24/2026

White House adviser Heidi Overton shapes ibogaine policy amid internal disputes.

7/24/2026

Psychoactive drug ibogaine gains attention for addiction treatment potential.